Stuttgart - Delayed Quote EUR
Blueprint Medicines Corp (2L9.SG)
87.28
+0.38
+(0.44%)
As of 8:08:37 AM GMT+2. Market Open.
Loading Chart for 2L9.SG
- Previous Close
86.90 - Open
87.28 - Bid 87.54 x --
- Ask 89.46 x --
- Day's Range
87.28 - 87.28 - 52 Week Range
66.48 - 111.15 - Volume
0 - Avg. Volume
46 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2L9.SG
View MorePerformance Overview: 2L9.SG
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
2L9.SG
3.19%
S&P 500 (^GSPC)
3.77%
1-Year Return
2L9.SG
12.42%
S&P 500 (^GSPC)
8.37%
3-Year Return
2L9.SG
71.88%
S&P 500 (^GSPC)
44.02%
5-Year Return
2L9.SG
45.86%
S&P 500 (^GSPC)
97.20%
Compare To: 2L9.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
91.63
-7.90%
Mkt Cap CNY 24.255B
Industry Biotechnology
Statistics: 2L9.SG
View MoreValuation Measures
As of 5/9/2025
Market Cap
5.59B
Enterprise Value
5.49B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.02
Price/Book (mrq)
18.41
Enterprise Value/Revenue
10.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--